No Data
Jefferies Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $31
Summit Therapeutics (SMMT) Gets a Buy From Jefferies
Express News | Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock market exploration | Performance and stock prices both soar! Citigroup and JPMorgan rise together; tenfold super stocks in ten years! The surgical robot company Intuitive Surgical hits a new historical high.
Fortune out of disaster? Carvana surged nearly 10% overnight. After a previous drop of 11% due to Hindenburg's short selling, Carvana has rebounded over 20% from its recent lows, and yesterday Hindenburg's short selling institution announced its dissolution.
Why Summit Therapeutics Rocketed 584% in 2024